Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADH1B | P00325 | 1/20 | 0.42 |
| ▸ | ADH1C | P00326 | 1/20 | 0.42 |
| ▸ | ADH1A | P07327 | 1/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 3/20 | 0.34 |
| ▸ | CA1 | P00915 | 2/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.33 |
| ▸ | MME | P08473 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17313812 | 1.00 | ADH1B (0.42) | ADH1BADH1CADH1ATP53CA2 | |
| SCHEMBL18823490 | 1.00 | ADH1B (0.42) | ADH1BADH1CADH1ATP53CA2 | |
| SCHEMBL18712598 | 1.00 | ADH1B (0.42) | ADH1BADH1CADH1ATP53CA2 | |
| SCHEMBL1241896 | 0.83 | ALDH1A1 (0.46) | ADH1BADH1CADH1ATP53ALDH1A1 | |
| SCHEMBL1241894 | 0.83 | ALDH1A1 (0.46) | ADH1BADH1CADH1ATP53ALDH1A1 | |
| SCHEMBL19932771 | 0.83 | ALDH1A1 (0.46) | ADH1BADH1CADH1ATP53ALDH1A1 | |
| SCHEMBL27805657 | 0.81 | CYP2C9 (0.36) | CA2CA1MMEMEN1KMT2A | |
| SCHEMBL9006398 | 0.81 | ADH1B (0.42) | ADH1BADH1CADH1ATP53ALDH1A1 | |
| Hydrochloric Acid SCHEMBL31244435 | 0.81 | ALDH1A1 (0.44) | ADH1BADH1CADH1ATP53ALDH1A1 | |
| SCHEMBL27258601 | 0.81 | ADH1B (0.42) | ADH1BADH1CADH1ATP53ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10696631-B2 | Chemical conjugates of evans blue derivatives and their use as radiotherapy and imaging agents | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2020-06-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10696631-B2 | Chemical conjugates of evans blue derivatives and their use as radiotherapy and imaging agents | H1-4, VIP, H1-3 | ADH1B 2573/4885ADH1C 1460/4885ADH1A 1144/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.